Analysis of the rat hypothalamus proteome by data-independent label-free LC-MS/MS

Proteomics

Volumn 12, Issue 22, 2012, Pages 3386-3392

  Stelzhammer, Viktoria ^a   Amess, Bob ^a   Martins de Souza, Daniel ^b   Levin, Yishai ^c   Ozanne, Susan E ^a   Martin Gronert, Malgorzata S ^a   Urday, Sebastian ^a   Bahn, Sabine ^d   Guest, Paul C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Animal proteomics; Hypothalamus; MS; Protein biomarker; Proteomics methods

Indexed keywords

GLUTAMIC ACID; MEMBRANE PROTEIN; PROTEOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CYTOSOL; DATA INDEPENDENT LABEL FREE NANO LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; HYPOTHALAMUS; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN FUNCTION; RAT; SYNAPSE;

ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; HYPOTHALAMUS; ISOELECTRIC POINT; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEOME; PROTEOMICS; RATS; RATS, WISTAR; TANDEM MASS SPECTROMETRY;

ANIMALIA; RATTUS;

EID: 84870156802     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100642     Document Type: Article

References (29)

1. Lightman, S. L., The neuroendocrine paraventricular hypothalamus: receptors, signal transduction, mRNA and neurosecretion. J. Exp. Biol. 1988, 139, 31-49.
2. Ulrich-Lai, Y. M., Herman, J. P., Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 2009, 10, 397-409.
3. Papadimitriou, A., Priftis, K. N., Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation 2009, 16, 265-271.
4. Conrad, C. D., Bimonte-Nelson, H. A., Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline. Prog. Brain Res. 2010, 182, 31-76.
5. Guilloteau, P., Zabielski, R., Hammon, H. M., Metges, C. C., Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J. Physiol. Pharmacol. 2009, 60(Suppl 3), 17-35.
6. Cutolo, M., Sulli, A., Pizzorni, C., Craviotto, C. et al., Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 2003, 992, 107-117.
7. Colagiuri, S., Diabesity: therapeutic options. Diabetes Obes. Metab. 2010, 12, 463-473.
8. Reynolds, R. M., Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. J. Steroid Biochem. Mol. Biol. 2010, 122, 3-9.
9. Phillips, J. A. III, Endocrine Disorders: Hereditary, John Wiley & Sons, Chichester 2006.
10. Taylor, G. T., Maloney, S., Dearborn, J., Weiss, J., Hormones in the mentally disturbed brain: steroids and peptides in the development and treatment of psychopathology. Cent. Nerv. Syst. Agents Med. Chem. 2009, 9, 331-360.
11. Levin, Y., Wang, L., Schwarz, E., Koethe, D. et al., Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol. Psychiatry 2010, 15, 1088-1100.
12. Ma, D., Chan, M. K., Lockstone, H. E., Pietsch, S. R. et al., Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex. J. Proteome Res. 2009, 8, 3284-3297.
13. Martins-de-Souza, D., Guest, P. C., Steeb, H., Pietsch, S. et al., Characterizing the proteome of the human dorsolateral prefrontal cortex by shotgun mass spectrometry. Proteomics 2011, 11, 2347-2353.
14. Wang, L., Lockstone, H. E., Guest, P. C., Levin, Y. et al., Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J. Proteome Res. 2010, 9, 521-527.
15. Krishnamurthy, D., Levin, Y., Harris, L. W., Umrania, Y. et al., Analysis of the human pituitary proteome by data independent label-free liquid chromatography tandem mass spectrometry. Proteomics 2011, 11, 495-500.
16. Li, G. Z., Vissers, J. P., Silva, J. C., Golick, D. et al., Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 2009, 9, 1696-1719.
17. Team, R. D. C., R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2009.
18. Muller, N., Schwarz, M. J., Immune system and schizophrenia. Curr. Immunol. Rev. 2010, 6, 213-220.
19. Martins-de-Souza, D., Is the word 'biomarker' being properly used by proteomics research in neuroscience? Eur. Arch Psychiatry Clin. Neurosci. 2010, 260, 561-562.
20. Ginsberg, S. D., Mufson, E. J., Alldred, M. J., Counts, S. E. et al., Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J. Chem. Neuroanat. 2011, 42, 102-110.
21. English, J. A., Dicker, P., Focking, M., Dunn, M. J. et al., 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 2009, 9, 3368-3382.
22. Pedersen, W. A., McCullers, D., Culmsee, C., Haughey, N. J. et al., Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 2001, 8, 492-503.
23. Kantrowitz, J. T., Javitt, D. C., Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. Clin. Schizophr. Relat. Psychoses. 2010, 4, 189-200.
24. Myers, K. M., Carlezon, W. A., Jr., Davis, M., Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 2010, 36, 274-293.
25. Jezova, D., Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications. Endocrine 2005, 28, 287-294.
26. Hensley, K., Venkova, K., Christov, A., Gunning, W. et al., Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 2011, 43, 180-191.
27. Berk, M., Ng, F., Dean, O., Dodd, S. et al., Glutathione: a novel treatment target in psychiatry. Trends Pharmacol. Sci. 2008, 29, 346-351.
28. Mukherjee, A., Soto, C., Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr. Opin. Cell Biol. 2011, 23, 223-230.
29. Lakshmikuttyamma, A., Selvakumar, P., Tuchek, J., Sharma, R. K., Myristoyltransferase and calcineurin: novel molecular therapeutic target for epilepsy. Prog. Neurobiol. 2008, 84, 77-84.